New Horizon Medical Solutions (NHMS), a leader in advanced wound care technologies, has announced a strategic collaboration with Soring, the U.S. affiliate of Söring (Germany), to distribute Söring's Ultrasonic-Assisted Wound (UAW) debridement system. The partnership aims to enhance wound treatment across various medical settings by combining advanced ultrasonic debridement with NHMS's biologically derived allograft products.
The Söring UAW system, which includes an ultrasonic generator and instrument, is designed for debridement and cleansing of chronic and acute wounds. It removes fibrin tissues, such as necroses, fibrin, scab, and pus, and breaks up biofilms, improving wound status and promoting healing in conditions like diabetic foot syndrome, decubitus ulcers, burns, post-surgical wounds, and post-traumatic wounds.
Jeffrey Alan Niezgoda, MD, FACHM, MAPWCA, CHWS, Chief Medical Officer of Kent Imaging and board member of NHMS, highlighted the synergy between the devices. "The use of SONOCA 185 and the UAW instruments for Ultrasonic Wound Debridement guided by SnapshotGLO and monitored by SnapshotNIR can significantly improve wound management and lead to better patient outcomes. These devices synergistically optimize wound bed preparation prior to CAMPs application," he said.
Will Hall, CEO of NHMS, emphasized the strategic importance of the collaboration. "This collaboration reflects our belief that the future of wound care lies in combining advanced technology with evidence-based clinical solutions. By bringing Söring's ultrasonic system into our portfolio, we're expanding access to innovative tools that address critical gaps in treatment while improving efficiency and outcomes across care settings," Hall stated.
NHMS is known for its biologically derived human placental allograft products, including amniotic membranes, placental tissues, and skin grafts for chronic wounds, surgical reconstruction, burns, and orthopedic procedures. The addition of Söring's ultrasonic debridement technology is expected to complement these products by improving wound bed preparation before graft application.
Söring, founded in 1985 and headquartered in Germany, specializes in ultrasonic tissue resection and ablation. The company develops medical technologies used globally, focusing on intuitive user experience and direct service to make surgical procedures more efficient and safer.
For more information, visit www.nhmedical.com.
